Background: Juvenile Systemic Lupus Erythematosus (jSLE) is a multisystem inflammatory disease associated with bone loss. However, some patients experience fractures prior to the impairment of bone mineral density (BMD), suggesting that other bone microarchitectural properties, including the Trabecular Bone Score (TBS), may contribute to an increased risk of fragility fractures. Purpose: To assess TBS values in patients diagnosed with jSLE; to compare them with data from an age- and sex-matched sample of healthy individuals; to associate TBS with BMD values; and to evaluate the correlation between TBS and clinical risk factors, fractures, and BMD. Research Design: An observational, analytical, retrospective study. Study Sample: Patients with jSLE aged between 5 and 19 years. Data Collection: Clinical data and BMD values obtained by DXA between 2017 and 2022 at a quaternary care center were analysed. The BMD and TBS data were compared with existing published data from healthy Brazilian children and adolescents after age and sex matching. Results: Ninety-four examinations from 50 jSLE patients were analysed. Twenty-one (22.3%) examinations showed significantly lower TBS values than controls. TBS was lower in female patients aged 14–16 and 17–19 years compared with their peers (1.381 vs 1.466 and 1.397 vs 1.479, respectively). BMD and TBS were concordant in 80/94 (85.1%) examinations, demonstrating a moderate and positive correlation (p < 0.0001). There was no correlation between TBS and previous fractures, disease duration, high disease activity, cumulative glucocorticoid dose, or the presence of fragility fractures. Conclusion: Patients with jSLE exhibited bone microarchitectural impairment, regardless of previous fragility fractures, disease duration, disease activity, or cumulative glucocorticoid exposure.
BultinkIEMVisMVan Der Horst-BruinsmaI, et al.Inflammatory rheumatic disorders and bone. Curr Rheumatol Rep2012; 14: 224–230. https://doi.org/10.1007/s11926-012-0252-8
AmarasekaraDSYuJRhoJ. Bone loss triggered by the cytokine network in inflammatory autoimmune diseases. J Immunol Res2015; 2015: 832127. https://doi.org/10.1155/2015/832127
6.
LaiEHuangWNChenHH, et al.Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosus. Arch Osteoporosis2020; 15: 54. https://doi.org/10.1007/s11657-020-00726-3
CouryFPeyruchaudOMachuca-GayetI. Osteoimmunology of bone loss in inflammatory rheumatic diseases. Front Immunol2019; 10: 679. https://doi.org/10.3389/fimmu.2019.00679
BuckleyLGuyattGFinkHA, et al.American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol2017; 69: 1095–1110. https://doi.org/10.1002/acr.23279
SilvaBCBilezikianJP. Trabecular bone score: perspectives of an imaging technology coming of age. Arq Bras Endocrinol Metabol2014; 58: 493–503. https://doi.org/10.1590/0004-2730000003456
16.
ShevrojaELamyOKohlmeierL, et al.Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice. J Clin Densitom2017; 20: 334–345. https://doi.org/10.1016/j.jocd.2017.06.019
17.
HarveyNCGlüerCCBinkleyN, et al.Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone2015; 78: 216–224. https://doi.org/10.1016/j.bone.2015.05.016
18.
SilvaBCWalkerMDAbrahamA, et al.Trabecular bone score is associated with volumetric bone density and microarchitecture as assessed by central QCT and HRpQCT in Chinese American and white women. J Clin Densitom2013; 16: 554–561. https://doi.org/10.1016/j.jocd.2013.07.001
19.
RuaroBCasabellaAPaolinoS, et al.Trabecular bone score and bone quality in systemic lupus erythematosus patients. Front Med2020; 7: 574842. https://doi.org/10.3389/fmed.2020.574842
20.
FragaMMSousaFPSzejnfeldVL, et al. Trabecular bone score (TBS) and bone mineral density (BMD) analysis by dual X‐ray absorptiometry (DXA) in healthy Brazilian children and adolescents: normative data. Arch Osteoporosis. 2023; 18: 82. https://doi.org/10.1007/s11657-023-01291-1
21.
PetriMOrbaiAMAlarcónGS, et al.Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64: 2677–2686. https://doi.org/10.1002/art.34473
22.
BombardierCGladmanDDUrowitzMB, et al.Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum1992; 35: 630–640. https://doi.org/10.1002/art.1780350606
23.
GenantHKWuCYVan KuijkC, et al.Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res1993; 8: 1137–1148. https://doi.org/10.1002/jbmr.5650080915
24.
KalkwarfHJShepherdJAHansD, et al.Trabecular bone score reference values for children and adolescents according to age, sex, and ancestry. J Bone Miner Res2022; 37: 776–785. https://doi.org/10.1002/jbmr.4520
25.
DowthwaiteJNWinzenriethRBinkleyN, et al.A focused evaluation of lumbar spine trabecular bone score in the first year post-menarche. Arch Osteoporosis2017; 12: 90. https://doi.org/10.1007/s11657-017-0388-2
26.
ParkSJSimSYJeongDC, et al.Factors affecting bone mineral density in children and adolescents with systemic lupus erythematosus. Ann Pediatr Endocrinol Metab2024; 29: 191–200. https://doi.org/10.6065/apem.2346060.030
27.
LillebyVLienGFreyFK, et al.Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum2005; 52: 2051–2059. https://doi.org/10.1002/art.21115
28.
KoumakisEAvouacJWinzenriethR, et al.Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposure. J Rheumatol2015; 42: 228–235. https://doi.org/10.3899/jrheum.140752
29.
ChoiYJChungYSSuhCH, et al.Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltim)2017; 96: e8661. https://doi.org/10.1097/MD.0000000000008661
30.
CorradoARotondoCMeleA, et al.Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis. Arthritis Res Ther2021; 23: 180. https://doi.org/10.1186/s13075-021-02562-3
31.
LeeKAKimJKimHJ, et al.Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid. Int J Rheum Dis2021; 24: 1053–1060. https://doi.org/10.1111/1756-185X.14164
32.
FlorezHHernandez-RodríguezJMuxiA, et al.Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. Rheumatology2020; 59: 1574–1580. https://doi.org/10.1093/rheumatology/kez464
33.
Nowakowska-PłazaAWronskiJSudol-SzopinskaI, et al.Clinical utility of trabecular bone score (TBS) in fracture risk assessment of patients with rheumatic diseases treated with glucocorticoids. Horm Metab Res2021; 53: 499–503. https://doi.org/10.1055/a-1528-7261
34.
WangXYanSLiuC, et al.Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int2016; 27: 1413–1423. https://doi.org/10.1007/s00198-015-3449-7
35.
KimCSHanKJungJH, et al.Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls. Korean J Intern Med (Engl Ed)2021; 36: 154–163. https://doi.org/10.3904/kjim.2018.378
